Dana-Farber Cancer Institute at Foxborough — Foxborough, Massachusetts

Dana-Farber Cancer Institute at Foxborough is a clinical research site located in Foxborough, Massachusetts, United States 02035.

Crixeo Health Trust Score: 77/100 (FAIR). This profile has not yet been claimed by the site owner.

Dana-Farber Cancer Institute at Foxborough has participated in 16 clinical trials with 16 currently active.

Therapeutic areas: Breast Cancer, Early-stage Breast Cancer, High Risk Breast Carcinoma.

Sponsors: Dana-Farber Cancer Institute, National Cancer Institute (NCI), ECOG-ACRIN Cancer Research Group.

Sponsor Feasibility Report

Trust Score: 77/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Dana-Farber Cancer Institute at Foxborough?

Dana-Farber Cancer Institute at Foxborough has a Crixeo Trust Score of 77/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Dana-Farber Cancer Institute at Foxborough conducted?

Dana-Farber Cancer Institute at Foxborough has 16 clinical trials on record, with 16 currently active. Their work covers Breast Cancer, Early-stage Breast Cancer, High Risk Breast Carcinoma.

Is Dana-Farber Cancer Institute at Foxborough accredited by Crixeo Health?

Yes — Dana-Farber Cancer Institute at Foxborough holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Dana-Farber Cancer Institute at Foxborough?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.